Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Non-Current Assets: 2017-2019

Historic Non-Current Assets for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $1.1 million.

  • Astria Therapeutics' Non-Current Assets rose 601.27% to $1.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.1 million, marking a year-over-year increase of 601.27%. This contributed to the annual value of $254,000 for FY2018, which is 41.47% down from last year.
  • Astria Therapeutics' Non-Current Assets amounted to $1.1 million in Q3 2019, which was down 27.96% from $1.5 million recorded in Q2 2019.
  • In the past 5 years, Astria Therapeutics' Non-Current Assets ranged from a high of $1.8 million in Q1 2019 and a low of $158,000 during Q3 2018.
  • Its 3-year average for Non-Current Assets is $685,273, with a median of $501,000 in 2017.
  • Per our database at Business Quant, Astria Therapeutics' Non-Current Assets slumped by 70.45% in 2018 and then skyrocketed by 837.80% in 2019.
  • Quarterly analysis of 3 years shows Astria Therapeutics' Non-Current Assets stood at $434,000 in 2017, then tumbled by 41.47% to $254,000 in 2018, then skyrocketed by 601.27% to $1.1 million in 2019.
  • Its Non-Current Assets was $1.1 million in Q3 2019, compared to $1.5 million in Q2 2019 and $1.8 million in Q1 2019.